| KCNA7 Protein |
|---|
| Protein Name | Voltage-gated potassium channel Kv1.7 |
| Gene | KCNA7 |
| UniProt ID | Q9Y2X3 |
| Category | Ion Channel Protein |
| Path | /proteins/kcna7-protein |
KCNA7 encodes the Kv1.7 voltage-gated potassium channel, a member of the Shaker-related potassium channel family. This channel plays a critical role in regulating neuronal and cardiac excitability by controlling potassium ion flow across cell membranes during action potential repolarization.
The Kv1.7 protein consists of:
- Six transmembrane domains (S1-S6) that form the voltage-sensing and pore-forming modules
- S4 voltage sensor region with positively charged residues that detect membrane potential changes
- P-loop (P region) between S5 and S6 that forms the ion selectivity filter
- N-terminal domain containing the T1 tetramerization domain that promotes channel assembly
- C-terminal domain involved in channel trafficking and localization
Like other Kv1 channels, Kv1.7 forms functional channels as tetramers, with each subunit contributing to the overall channel complex.
Kv1.7 is a voltage-gated potassium channel that:
- Opens in response to membrane depolarization
- Allows rapid efflux of potassium ions during action potential repolarization
- Contributes to setting the resting membrane potential
- Regulates neuronal firing patterns and frequency
Kv1.7 expression includes:
- Heart: Cardiac myocytes where it contributes to action potential repolarization
- Brain: Various neuronal populations, though expression levels are lower than Kv1.1-Kv1.6
- Smooth muscle: Vascular and visceral smooth muscle cells
- Pancreas: Insulin-secreting beta cells
- Neuronal repolarization: Contributes to the rapid phase of action potential repolarization in neurons
- Calcium signaling regulation: By controlling repolarization, indirectly regulates calcium entry through voltage-gated calcium channels
- Neurotransmitter release: Potassium channel activity influences presynaptic terminal excitability and neurotransmitter release
Voltage-gated potassium channels, including Kv1.7, are implicated in epilepsy pathogenesis:
- Dysregulation of neuronal excitability due to potassium channel dysfunction can contribute to seizure generation
- Genetic variants in KCNA7 may alter channel function and neuronal excitability
- Potassium channel openers have been explored as potential antiepileptic therapies
Emerging research suggests potassium channel dysfunction may play a role in Parkinson's disease:
- Substantia nigra dopaminergic neurons exhibit altered potassium channel expression in PD models
- Kv1.7 may contribute to neuronal survival mechanisms in dopaminergic neurons
- Ion channel dysfunction can exacerbate alpha-synuclein toxicity
Potassium channels are indirectly implicated in Alzheimer's disease:
- Amyloid-beta peptide affects neuronal potassium channel function
- Altered channel activity may contribute to synaptic dysfunction
- Potassium channel modulators are being investigated for neuroprotective effects
KCNA7 variants have been associated with cardiac arrhythmias:
- Loss-of-function mutations can prolong cardiac action potential
- May contribute to long QT syndrome in some cases
- Interacts with other cardiac ion channels to maintain proper electrical conduction
Kv1.7 represents a potential drug target for:
- Epilepsy: Potassium channel openers to reduce neuronal excitability
- Pain: Kv1.7 inhibitors for analgesic effects
- Cardiac disorders: Modulators to normalize cardiac rhythm
- Agonists: Retigabine and other potassium channel openers
- Antagonists: Various toxins and small molecule inhibitors (e.g., correolide)
- Genetic tools: CRISPR-Cas9 for studying channel function
- Knockout mice: KCNA7-/- mice show cardiac phenotype but relatively mild neurological effects
- Transgenic models: Overexpression studies to investigate channel dysfunction
- Zebrafish models: Used for developmental studies of channel function
Kv1.7 interacts with:
- KCNA proteins: Co-assembly with other Kv1 family members
- beta subunits: KVβ1 and KVβ2 can modulate channel properties
- Ankyrin-G: For proper membrane localization
- PDZ domain proteins: Scaffolding proteins that anchor channels
- KCNA7 characterization and functional analysis (2017)
- Voltage-gated potassium channels: structure, function, and pharmacology (2020)
- Potassium channels in epilepsy: therapeutic implications (2019)
- Kv channel dysfunction in Parkinson's disease models (2021)
- Amyloid-beta effects on neuronal ion channels (2018)
- Molecular biology of voltage-gated potassium channels (2022)